Leadless pacemakers are redefining standard of care for bradycardia towards improved heart care: Expert: Shardul Nautiyal, Mumbai Monday, October 20, 2025, 09:00 Hrs [IST] Leadles ...

In the intent-to-treat population, the median progression-free survival (PFS) was 8.77 months with giredestrant plus Afinitor ...

PITTSBURGH, Oct. 13, 2025 /PRNewswire/ — PANTHERx ® Rare has been chosen by Chiesi as the exclusive specialty pharmacy to ...

Javadin is a berry-flavored, clear, colorless oral solution. Each 5 mL delivers 0.1 mg of clonidine (0.02 mg/mL). Javadin may be used alone or in combination with other antihypertensive agents.

Conventional pacemakers, with their transvenous leads, have long been the standard of care globally, including in India.

Lindsey Valenzuela, PharmD, explains how pharmacists can prevent drug interactions and improve coordination for women with ...

Detailed price information for Harmony Biosciences Holdings Inc (HRMY-Q) from The Globe and Mail including charting and trades.

Key points A 68-year-old woman from rural Ontario arrived at her local emergency department with worsening palpitations. Her medical history included breast cancer treated with surgical resection and ...

Pacemakers have long been central to managing various heart conditions, among which is bradycardia – a condition characterized by an abnormally slow heart rate, defined as fewer than 60 beats […] ...

About Chiesi Group Chiesi is a research-oriented international biopharmaceutical group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty ...